298 related articles for article (PubMed ID: 33392639)
1. The use of zebrafish model in prostate cancer therapeutic development and discovery.
Amawi H; Aljabali AAA; Boddu SHS; Amawi S; Obeid MA; Ashby CR; Tiwari AK
Cancer Chemother Pharmacol; 2021 Mar; 87(3):311-325. PubMed ID: 33392639
[TBL] [Abstract][Full Text] [Related]
2. Drug discovery in prostate cancer mouse models.
Valkenburg KC; Pienta KJ
Expert Opin Drug Discov; 2015; 10(9):1011-24. PubMed ID: 26027638
[TBL] [Abstract][Full Text] [Related]
3. Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer.
Butler MS; Roshan-Moniri M; Hsing M; Lau D; Kim A; Yen P; Mroczek M; Nouri M; Lien S; Axerio-Cilies P; Dalal K; Yau C; Ghaidi F; Guo Y; Yamazaki T; Lawn S; Gleave ME; Gregory-Evans CY; McIntosh LP; Cox ME; Rennie PS; Cherkasov A
Oncotarget; 2017 Jun; 8(26):42438-42454. PubMed ID: 28465491
[TBL] [Abstract][Full Text] [Related]
4. Zebrafish xenograft models of cancer and metastasis for drug discovery.
Brown HK; Schiavone K; Tazzyman S; Heymann D; Chico TJ
Expert Opin Drug Discov; 2017 Apr; 12(4):379-389. PubMed ID: 28277839
[TBL] [Abstract][Full Text] [Related]
5. Characterization of prostate cancer cell progression in zebrafish xenograft model.
Xu W; Foster BA; Richards M; Bondioli KR; Shah G; Green CC
Int J Oncol; 2018 Jan; 52(1):252-260. PubMed ID: 29115578
[TBL] [Abstract][Full Text] [Related]
6. Zebrafish: Speeding Up the Cancer Drug Discovery Process.
Letrado P; de Miguel I; Lamberto I; Díez-Martínez R; Oyarzabal J
Cancer Res; 2018 Nov; 78(21):6048-6058. PubMed ID: 30327381
[TBL] [Abstract][Full Text] [Related]
7. Computer-aided drug discovery of Myc-Max inhibitors as potential therapeutics for prostate cancer.
Carabet LA; Lallous N; Leblanc E; Ban F; Morin H; Lawn S; Ghaidi F; Lee J; Mills IG; Gleave ME; Rennie PS; Cherkasov A
Eur J Med Chem; 2018 Dec; 160():108-119. PubMed ID: 30326371
[TBL] [Abstract][Full Text] [Related]
8. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
[TBL] [Abstract][Full Text] [Related]
9. Drug development for metastatic castration-resistant prostate cancer: current status and future perspectives.
Lassi K; Dawson NA
Future Oncol; 2011 Apr; 7(4):551-8. PubMed ID: 21463143
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo culture of human prostate tissue and drug development.
Centenera MM; Raj GV; Knudsen KE; Tilley WD; Butler LM
Nat Rev Urol; 2013 Aug; 10(8):483-7. PubMed ID: 23752995
[TBL] [Abstract][Full Text] [Related]
11. Utilizing Zebrafish to Identify Anti-(Lymph)Angiogenic Compounds for Cancer Treatment: Promise and Future Challenges.
Okuda KS; Lee HM; Velaithan V; Ng MF; Patel V
Microcirculation; 2016 Aug; 23(6):389-405. PubMed ID: 27177346
[TBL] [Abstract][Full Text] [Related]
12. The Use of the Zebrafish Model to Aid in Drug Discovery and Target Validation.
Yoganantharjah P; Gibert Y
Curr Top Med Chem; 2017; 17(18):2041-2055. PubMed ID: 28137236
[TBL] [Abstract][Full Text] [Related]
13. Zebrafish: a complete animal model for in vivo drug discovery and development.
Chakraborty C; Hsu CH; Wen ZH; Lin CS; Agoramoorthy G
Curr Drug Metab; 2009 Feb; 10(2):116-24. PubMed ID: 19275547
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic modulation of prostate cancer metastasis.
Krishna SN; Bergan RC
Future Med Chem; 2014 Feb; 6(2):223-39. PubMed ID: 24467245
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
16. Using zebrafish models of leukemia to streamline drug screening and discovery.
Deveau AP; Bentley VL; Berman JN
Exp Hematol; 2017 Jan; 45():1-9. PubMed ID: 27720937
[TBL] [Abstract][Full Text] [Related]
17. Zebrafish as a Model Organism for the Development of Drugs for Skin Cancer.
Bootorabi F; Manouchehri H; Changizi R; Barker H; Palazzo E; Saltari A; Parikka M; Pincelli C; Aspatwar A
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718799
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer.
Zoni E; Astrologo L; Ng CKY; Piscuoglio S; Melsen J; Grosjean J; Klima I; Chen L; Snaar-Jagalska EB; Flanagan K; van der Pluijm G; Kloen P; Cecchini MG; Kruithof-de Julio M; Thalmann GN
Mol Cancer Res; 2019 May; 17(5):1049-1062. PubMed ID: 30745464
[TBL] [Abstract][Full Text] [Related]
19. Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery.
Fontana F; Raimondi M; Marzagalli M; Sommariva M; Gagliano N; Limonta P
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948069
[TBL] [Abstract][Full Text] [Related]
20. Flight for fish in drug discovery: a review of zebrafish-based screening of molecules.
Dash SN; Patnaik L
Biol Lett; 2023 Aug; 19(8):20220541. PubMed ID: 37528729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
